<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the effect of SAS on the long term memory in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients and compared them with patients with <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> or <z:hpo ids='HP_0000518'>cataract</z:hpo> (control group), respectively </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients develop SAS and <z:hpo ids='HP_0100543'>cognitive impairments</z:hpo> more often then healthy people </plain></SENT>
<SENT sid="2" pm="."><plain>Since SAS leads to a fragmentation of the sleep structure it interferes with memory </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore SAS may be a pathogenic factor of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We studied 14 patients (7 with and 7 without SAS) with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> or <z:hpo ids='HP_0000518'>cataract</z:hpo> using the LGT-3, which measures the verbal, numeric and figural long term memory </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients answered subtest 7 of the Wechsler-Memory-Scale at night and in the morning </plain></SENT>
<SENT sid="6" pm="."><plain>The saving between the evening and morning measure was calculated </plain></SENT>
<SENT sid="7" pm="."><plain>An analysis of variance was performed using the SAS-condition and the different groups as independent variable </plain></SENT>
<SENT sid="8" pm="."><plain>A significant difference (p &lt; or = 0.005) of <z:hpo ids='HP_0000001'>all</z:hpo> memory measurements between patients with and without SAS but not between the different groups has been proved with a superiority of the patients without SAS </plain></SENT>
<SENT sid="9" pm="."><plain>A significant difference of the influence of the SAS for verbal memory score on patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> (pp &lt; or = 0.05) and <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (pp &lt; or = 0.005) respectively and the control group could be demonstrated </plain></SENT>
<SENT sid="10" pm="."><plain>Therefore we found a quantitative difference of memory consolidation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients with SAS </plain></SENT>
<SENT sid="11" pm="."><plain>The influence of SAS on memory in patients with <z:e sem="disease" ids="C0027765" disease_type="Disease or Syndrome" abbrv="">neurological disease</z:e> is more pronounced compared to the control group </plain></SENT>
</text></document>